MENU

Eureka projects

Development of the use of tumour necrosis factor related apoptosis inducing ligand or apo2 ligand (trail) as an efficient anti-tumour therapy as an alternative to chemo/radiotherapy.
Project ID: 
2928

Personalised medicine has been targeted as the most important future development in both medicine and drug development. The final product that synergistically combines the two companies' capabilities will be a software platform.
Project ID: 
3857

The aim of this project is the development of an automatic platform for processing bloodchip(r), a progenika's dna array for blood genotyping, which will allow to reduce costs and to increase traceability, efficiency and quality of the process.
Project ID: 
7212

Multi-platform Colorectal Cancer Genetic Testing Portfolio
Eurostars-1 cut-off: 
1
Ranking: 
109
Project ID: 
4292

Absolute Quantification of Proteins in Mass Spectrometers for Diagnostic Use
Eurostars-1 cut-off: 
2
Ranking: 
33
Project ID: 
4655

Biotechnology tools for improving disease resistance and seed quality in legumes
Eurostars-1 cut-off: 
2
Ranking: 
14
Project ID: 
4770

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.